C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,620 | -83,892 | -68,234 | -43,551 | -20,971 |
| Depreciation Amortization | 1,145 | 4,090 | 2,741 | 1,673 | 735 |
| Accounts receivable | 3,944 | -1,232 | -361 | -1,729 | 828 |
| Accounts payable and accrued liabilities | -1,152 | -1,179 | -1,939 | -1,338 | -1,965 |
| Other Working Capital | -6,243 | -30,090 | -11,940 | -10,778 | -8,863 |
| Other Operating Activity | 7,330 | 25,338 | 18,439 | 12,787 | 5,302 |
| Operating Cash Flow | $-26,596 | $-86,965 | $-61,294 | $-42,936 | $-24,934 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -76,219 | -188,059 | -392,324 | -237,622 | -176,303 |
| PPE Investments | -172 | -1,277 | -1,168 | -1,168 | -421 |
| Sale Of Investment | 72,387 | N/A | 263,569 | 209,494 | 114,994 |
| Investing Cash Flow | $-4,004 | $-189,336 | $-129,923 | $-29,296 | $-61,730 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 260 | 171,795 | 171,043 | 170,639 | 166 |
| Other Financing Activity | 220 | -395 | -109 | -289 | -317 |
| Financing Cash Flow | $480 | $171,400 | $170,934 | $170,350 | $-151 |
| Beginning Cash Position | 79,403 | 184,304 | 184,304 | 184,304 | 184,304 |
| End Cash Position | 49,283 | 79,403 | 164,021 | 282,422 | 97,489 |
| Net Cash Flow | $-30,120 | $-104,901 | $-20,283 | $98,118 | $-86,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,596 | -86,965 | -61,294 | -42,936 | -24,934 |
| Capital Expenditure | -172 | -1,277 | -1,168 | -1,168 | -421 |
| Free Cash Flow | -26,768 | -88,242 | -62,462 | -44,104 | -25,355 |